Table 8.

Relationships between expression levels of glycolysis-related genes and the clinical parameters of cervical cancer patients

Characteristics, n = 300	ALDOA			ENO3			GPI			LDHA			PGK1			PKM
	high	low	p	high	low	p	high	low	p	high	low	p	high	low	p	high	low	p
Histological classification			< 0.001			< 0.001			< 0.001			0.03			0.03			< 0.001
Squamous cell carcinoma	139	113		111	141		138	114		133	119		133	119		140	112
Adeno-carcinoma	11	37		39	9		12	36		17	31		17	31		10	38
Primary tumor			0.03			0.45			0.003			0.29			< 0.001			0.51
T1-T2	94	113		105	102		92	115		96	111		89	118		97	110
T3-T4	20	10		13	17		22	8		17	13		24	6		16	14
Lymph node invasion			0.07			0.91			0.05			0.42			0.67			0.15
N0	54	76		65	65		53	77		60	70		53	77		56	74
N1	33	26		29	30		33	26		31	28		26	33		32	27
FIGO stage			0.01			0.65			0.03			0.07			0.01			0.17
Stage I-II	103	125		116	112		105	123		108	120		105	123		108	120
Stage III-IV	42	23		31	34		40	25		39	26		42	23		37	28
Treatment type			0.13			0.3			0.3			0.03			0.08			0.42
Pharmaceutical Therapy, NOS	67	80		69	78		69	78		64	83		66	81		77	70
Radiation Therapy, NOS	83	70		81	72		81	72		86	67		84	69		73	80

The chi-square tests were used for statistical analyses

Abbreviations: FIGO Federation International of Gynecology and Obstetrics